Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Therachon
221
Therachon
Technology
Biotechnology
We are focused on developing treatments for rare, genetic diseases. Our lead pipeline candidate is in development for achondroplasia or short-limbed dwarfism.
Suggest edits
Raised
$60M
Follow us
Companies in the same industry
MannKind Corporation
Cepheid
Immune Design
CRISPR Therapeutics
AngioScore
AIT Bioscience
Amedica
Intentiva Inc.
Alzheon
BaroFold
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Add round
09 Aug
2018
$60,000,000
Venture capital (Series B)
Bpifrance
,
Versant Ventures
,
OrbiMed
,
+5
